Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cidara Therapeutics, Inc. | 0 | reported | 07 Jan 2026 | tx 14+152,225−35,375 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 11,100 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 16,000 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 2,125 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 2,125 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 1,400 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 875 | — | deriv |
| 07 Jan 2026 | OTHER | Cidara Therapeutics, Inc. | 1,750 | — | deriv |
| 18 Jun 2025 | GRANT_AWARD | Cidara Therapeutics, Inc. | 11,100 | 0.00 USD | deriv |
| 17 Dec 2024 | GRANT_AWARD | Cidara Therapeutics, Inc. | 16,000 | 0.00 USD | deriv |
| 18 Jul 2024 | GRANT_AWARD | Cidara Therapeutics, Inc. | 2,125 | 0.00 USD | deriv |
| 22 Jun 2023 | GRANT_AWARD | Cidara Therapeutics, Inc. | 42,500 | 0.00 USD | deriv |
| 22 Jun 2022 | GRANT_AWARD | Cidara Therapeutics, Inc. | 28,000 | 0.00 USD | deriv |
| 23 Jun 2021 | GRANT_AWARD | Cidara Therapeutics, Inc. | 17,500 | 0.00 USD | deriv |
| 22 Jan 2021 | GRANT_AWARD | Cidara Therapeutics, Inc. | 35,000 | 0.00 USD | deriv |